Trial reportBMC oral health2026
Clinical efficacy and patient-reported outcomes of coconut oil as adjunctive periodontitis treatment: triple-blinded pilot randomized trial.
Trial report in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06049589 (Therapeutic Application of Coconut Oil in Oral Health), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Therapeutic Application of Coconut Oil in Oral Health
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeriodontitis is a prevalent chronic disease commonly managed with nonsurgical therapy and adjunctive antimicrobial rinses, though their side effects can hinder long-term use. Coconut oil has emerged as a potential natural alternative due to its antimicrobial and anti-inflammatory effects. This study aimed to evaluate the clinical and patient-reported outcomes of periodontal patients treated with nonsurgical therapy with or without coconut oil as an adjunctive method.
methodsThirty participants with stage II-III periodontitis were randomly assigned to three groups: coconut oil, 0.12% chlorhexidine, and placebo (coconut-flavored water) mouth rinse for one month, followed by nonsurgical periodontal therapy. A blinded examiner assessed the plaque index, bleeding on probing, probing pocket depth, clinical attachment level, saliva pH, tooth color, sulfur compounds in breath, and patient-reported outcomes, including the Oral Health Impact Profile-14 before starting the use of mouth rinse (T1), one month after starting the mouth rinse (T2) and one month after nonsurgical periodontal therapy (T3).
resultsCompared with the placebo, both coconut oil and chlorhexidine significantly reduced the plaque index at T2 (p = 0.001; p = 0.006), bleeding on probing at T2 (p = 0.001; p = 0.001) and T3 (p = 0.006; p = 0.009), probing depth at T2 (p = 0.001; p = 0.001), clinical attachment level at T2 (p = 0.001; p = 0.015) and sulfur compounds at T2(p = 0.045; p = 0.003). Compared with chlorhexidine, coconut oil was more effective at decreasing clinical attachment loss at T2 (p = 0.006). At T2, chlorhexidine was associated with increased burning sensation (p = 0.03) and color changes (p < 0.001), whereas coconut oil reduced the degree of mouth dryness perception (p < 0.001). Coconut oil and chlorhexidine improved breath perception (p = 0.003; p = 0.030). Patients preferred the placebo over coconut oil or chlorhexidine (p = 0.006; p = 0.015). The quality of life significantly improved in the coconut oil group at T2 (p = 0.024).
conclusionsCompared with placebo, coconut oil and chlorhexidine improved periodontal parameters. However, coconut oil reduces mouth dryness and improves quality of life without the adverse effects associated with chlorhexidine. Nonetheless, participants in the placebo group reported a higher preference for the mouth rinse, suggesting that taste and mouthfeel play a crucial role in patient compliance. ETHICAL APPROVAL AND
trial registrationThe study protocol was approved by the Comité de Ética de la Investigación con Medicamentos de Galicia (CEIm-G) under protocol number 2017/247, registered at ClinicalTrials.gov (NCT06049589) on September 1st 2023 and conducted in compliance with the Declaration of Helsinki and Good Clinical Practice guidelines. All participants provided written informed consent before enrollment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.